SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-20-071680
Filing Date
2020-03-12
Accepted
2020-03-12 16:56:13
Documents
6

Document Format Files

Seq Description Document Type Size
1 424B5 d899089d424b5.htm 424B5 191295
2 GRAPHIC g899089g68t19.jpg GRAPHIC 51096
3 GRAPHIC g899089g70a24.jpg GRAPHIC 42903
4 GRAPHIC g899089g71j54.jpg GRAPHIC 76905
5 GRAPHIC g899089g80u98.jpg GRAPHIC 18635
6 GRAPHIC g899089g93l01.jpg GRAPHIC 62457
  Complete submission text file 0001193125-20-071680.txt   539855
Mailing Address 245 FIRST STREET CAMBRIDGE MA 02142
Business Address 245 FIRST STREET CAMBRIDGE MA 02142 617-871-2098
Akebia Therapeutics, Inc. (Filer) CIK: 0001517022 (see all company filings)

IRS No.: 208756903 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-223585 | Film No.: 20709545
SIC: 2834 Pharmaceutical Preparations